Adolescence represents a critical transitional phase marked by rapid physical maturation, psychosocial exploration, and shifting peer dynamics. In Nigeria, young people aged 10 to 19 years constitute a significant demographic proportion, yet they bear a disproportionate burden of sexually transmitted infections (STIs) and human immunodeficiency virus (HIV). Epidemiological data consistently highlight that new HIV infections and curable bacterial STIs, such as gonorrhea, chlamydia, and syphilis, peak during youth and early adulthood. Several compounding structural and systemic realities drive these numbers. Youth in urban slums, rural communities with limited healthcare access, and out-of-school settings face amplified risks due to early sexual debut, transactional sex driven by economic vulnerability, and compressed access to accurate reproductive health information. Public health surveillance indicates that female adolescents contract HIV at significantly higher rates than their male peers of the same age group, a disparity rooted in gender power imbalances and biological susceptibility. Understanding these epidemiological trends allows nursing professionals to target preventive interventions effectively and advocate for policy changes tailored to youth demographics.
The heightened susceptibility of adolescents to STIs and HIV stems from an intricate overlap of biological, psychological, and social factors.
Adolescents frequently present with both ulcerative and non-ulcerative STIs that can cause severe long-term reproductive morbidity if left untreated.
Human immunodeficiency virus targets cells bearing CD4 surface receptors, primarily helper T-lymphocytes and macrophages, leading to progressive immune system deterioration. Transmission among adolescents occurs predominantly through unprotected heterosexual intercourse, vertical transmission from infected mothers during birth or breastfeeding (diagnosed in adolescence as long-term survivors), and occasionally through unsafe sharing of sharp instruments. Following acute infection, adolescents experience a brief seroconversion illness characterized by flu-like symptoms. Without antiretroviral therapy, the virus replicates steadily over years, gradually depleting the CD4 count and advancing through clinical stages defined by the World Health Organization (WHO), from mild mucocutaneous manifestations to severe opportunistic infections such as tuberculosis, cryptococcal meningitis, and Kaposi's sarcoma. Adolescent immune systems can sometimes mount a vigorous initial defense, but the psychological stressors of adolescence often impair adherence, accelerating disease progression.
Comprehensive nursing assessment for adolescents requires establishing trust, ensuring strict confidentiality, and conducting a non-judgmental sexual history. Nurses must screen for risky behaviors, substance use, and history of forced sexual encounters. Diagnostic testing for STIs involves nucleic acid amplification tests (NAATs) using urine or swab samples for chlamydia and gonorrhea, wet mount microscopy for trichomoniasis, and serological tests for syphilis. For HIV, screening is typically performed using rapid diagnostic testing (RDT) algorithms in line with national guidelines, followed by confirmatory testing if reactive. A critical concept for nurses to remember is the diagnostic window period—the time between initial infection and the development of detectable antibodies. An adolescent tested immediately after a high-risk exposure may yield a false-negative result on an antibody test, necessitating repeat testing or use of antigen-based assays.
Management of STIs and HIV in adolescents requires targeted antimicrobial regimens and lifelong viral suppression therapies. Bacterial STIs are treated with specific antibiotics, such as intramuscular ceftriaxone and oral azithromycin for gonorrhea and chlamydia, with mandatory partner notification and treatment to prevent reinfection. For HIV-positive adolescents, Antiretroviral Therapy (ART) is initiated immediately regardless of CD4 count. Regimens typically combine two nucleoside reverse transcriptase inhibitors (NRTIs) with an integrase strand transfer inhibitor (INSTI) or a non-nucleoside reverse transcriptase inhibitor (NNRTI). Adherence is the single greatest predictor of treatment success in this age group. Nurses must address pill fatigue, body image concerns related to lipodystrophy or weight changes, and the fear of inadvertent disclosure to peers or family members, which often leads to missed doses and viral resistance.
Traditional adult hospital clinics often fail to retain young people due to rigid appointment schedules, long waiting queues, judgmental attitudes from healthcare staff, and breaches of confidentiality. Adolescent-Friendly Health Services (AFHS) provide a welcoming, accessible, and acceptable environment where youth can seek reproductive health care without fear or shame. Key pillars of AFHS include equitable and non-discriminatory service delivery, convenient operating hours, affordable or free services, and active involvement of youth in peer education and support groups. Psychosocial support is equally critical; nurses must assess mental health indicators such as depression, anxiety, and suicidal ideation, which occur at higher rates among youth living with chronic stigmatized conditions. Creating safe spaces for peer counseling helps adolescents build resilience and cope with their diagnosis effectively.
Preventing STIs and HIV among youth requires a multi-layered approach combining biomedical interventions, comprehensive education, and community advocacy. Biomedical prevention includes promoting correct and consistent condom use, offering pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for high-risk individuals, and administering human papillomavirus (HPV) vaccines. Health education must be accurate, age-appropriate, and free from moralistic bias, empowering adolescents to make informed decisions about their bodies. Stigma remains a massive barrier to testing and treatment; nurses play an active role in community sensitization programs to dispel myths, reduce discrimination against infected youth, and advocate for supportive societal policies that protect the health rights of young people.